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Background: Earthworm hemoglobin (LtHb) is a potential blood substitute.
Results: LtHb can generate nitric oxide (NO) and preserve NO bioactivity.
Conclusion: LtHb reactions with nitrite and NO are indicative of therapeutic possibilities.
Significance: The results further highlight the potential role of hemoglobins in NO homeostasis.
The giant extracellular hemoglobin (erythrocruorin) from the
earth worm (Lumbricus terrestris) has shown promise as a
potential hemoglobin-based oxygen carrier (HBOC) in in vivo
animal studies. An important beneficial characteristic of this
hemoglobin (LtHb) is the large number of heme-based oxygen
transport sites that helps overcome issues of osmotic stress
when attempting to provide enough material for efficient oxy-
gen delivery. A potentially important additional property is the
capacity of the HBOC either to generate nitric oxide (NO) or to
preserve NO bioactivity to compensate for decreased levels of
NO in the circulation. The present study compares theNO-gen-
erating and NO bioactivity-preserving capability of LtHb with
that of human adult hemoglobin (HbA) through several reac-
tions including the nitrite reductase, reductive nitrosylation,
and still controversial nitrite anhydrase reactions. An assign-
ment of a heme-bounddinitrogen trioxide as the stable interme-
diate associated with the nitrite anhydrase reaction in both
LtHb and HbA is supported based on functional and EPR spec-
troscopic studies. The role of the redox potential as a factor
contributing to theNO-generating activity of these two proteins
is evaluated. The results show that LtHb undergoes the same
reactions as HbA and that the reduced efficacy for these reac-
tions for LtHb relative to HbA is consistent with the much
higher redox potential of LtHb. Evidence of functional hetero-
geneity in LtHb is explained in terms of the large difference in
the redox potential of the isolated subunits.
Acellular hemoglobins as hemoglobin-based oxygen carriers
(HBOCs)2 have been the focus of attempts to develop oxygen
transport therapeutics that could effectively replace conven-
tional red blood cell-based transfusions. However, no Food and
Drug Administration-approved product exists because of the
inherent limitations associatedwith infusion of acellular hemo-
globins as HBOCs. One limiting factor is the low number of
oxygen binding sites in most HBOCs such as human adult
hemoglobin (HbA) that restricts the amount of protein that can
be infused into the body because of the potential for high vas-
cular osmotic stress. The second limiting factor is HBOC tox-
icity. A major source of this toxicity comes from efficient nitric
oxide (NO) scavenging by acellularHbs (1, 2). TheNO scaveng-
ing occurs primarily through the nitric oxide dioxygenase reac-
tion in which oxygen bound to the heme reacts with circulating
NO to form nitrate and ferric heme. NO depletion through this
reaction directly causes proinflammatory conditions including
vasoconstriction and enhanced platelet aggregation, defeating
the purpose of the transfusion. The last form of toxicity of
HBOCs comes frommet heme, which can form from either the
nitric oxide dioxygenase reaction or the autoxidation of oxy-
gen-bound heme that also generates reactive oxygen species (3,
4). Both met heme and reactive oxygen species can be
proinflammatory.
Thus, to be effective, an HBOC requires properties such that
it counteracts high osmotic stress, low oxygen carrying capac-
ity, and NO scavenging as well as any other acellular Hb-de-
rived toxicity. Attempts to overcome the osmotic issue have
taken the form of generating polymeric forms of mammalian
hemoglobins; however, most still scavenge NO and are vasoac-
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through recombinant technology that generates Hbs with low
rates of nitric oxide dioxygenase (1). Alternatively it can be
addressed through several proposed and studied hemoglobin-
based reactions with nitrite (5–11) that can compensate forNO
scavenging by generating NO and related bioactive forms of
NOmolecules or stableHb species that preserveNObioactivity
(12–14).
In the quest for suitable blood substitutes, one candidate that
has drawn some attention is the hemoglobin from the earth-
worm (Lumbricus terrestris) (15–25). A closely related worm
hemoglobin from Arenicola marina is currently being evalu-
ated as an HBOC in France (16, 26). The acellular hemoglobins
from these worms are very large polymeric hemoglobins with
many oxygen binding sites. The acellular hemoglobin from the
earth worm (LtHb) is of interest because each molecule con-
tains 144 oxygen binding hemes, significantly more than HbA,
which contains only four. In addition, LtHb has a high redox
potential (27). The redox potential is a measure of the tendency
of the heme to undergo reduction. The high redox potential is a
likely origin of the high stability of LtHb as a ferrous species
(low rate of oxidation/met formation). Unlike HbA, LtHb does
not readily dissociate into smaller polymeric units upon dilu-
tion under physiological conditions. These factors are all posi-
tive with respect to efficacy as a potent HBOC.Most significant
is that the large oxygen carrying capacity of each molecule per-
mits the use ofmuch lower concentrations of infused protein to
achieve needed therapeutic levels of delivered oxygen. As a
result, the use of LtHb overcomes the osmotic limitations that
prevent achieving therapeutic levels of oxygen when infusing
HBOCs with much fewer oxygen binding sites. In vivo studies
(17, 18) have demonstrated that LtHb can be effective in deliv-
ering oxygenwithout obvious toxic consequences. Additionally
there is evidence (18, 26) that the rate for the nitric oxide dioxy-
genase reaction for both of these multimeric giant Hbs is much
lower than for HbA, suggesting that NO scavenging many not
be as big an issue for these species if used as HBOCs. The cur-
rent project addresses the remaining important issue of the
ability of LtHb to overcome any potential NO scavenging
through compensatory reactions that generate NO and long
lived forms ofNO. There is growing evidence that acellularHbs
frommany invertebrates play a role in NO-related homeostasis
(28, 29).
One reaction often invoked as a possible mechanism of gen-
erating NO from Hbs is the nitrite reductase (NR) reaction (8,
10, 11) (Reaction 1), which results in the production ofNO from
the reaction of five-coordinate ferrous hemoglobin (i.e. deoxy-
hemoglobin) and nitrite.
NO2
  HbFe2  H¡ NO●HbFe3OH
REACTION 1
The rate of this reaction for tetrameric hemoglobin is depen-
dent upon the quaternary state of the protein (30–32). It has
been shown that R state proteins undergo the NR reaction
much faster than T state proteins. The dependence of this reac-
tion on quaternary state is attributable at least in part to the
effect of quaternary state on the redox potential of the heme
(31, 33, 34). A high redox potential indicates that the reduced
(Fe2) form of heme is favored. The T state structure of HbA
has a higher redox potential relative to the R state. As a conse-
quence, the NR reaction, which involves going from the
reduced form of heme to the oxidized form, is favored by the
lower redox potential of the R state. The implication is that
heme proteins with higher redox potentials will have lower NR
rates. Furthermore, the NR reaction appears to be particularly
important for HBOC studies: HBOCs that display high NR
rates generally show the lowest levels of induced vasoconstric-
tion (35). However, forNO-related reactions to counterbalance
scavenging, it is likely that the Hb must generate either long
lasting bioactive forms of NO as opposed to the very short lived
vascular NO or form derivatives that preserve NO bioactivity.
In this respect, the NR reaction appears inadequate and is likely
to be only one part of a larger process.Most recently it has been
shown that this reaction, occurring in red blood cells, is associ-
ated with processes that reduce platelet activity (decreases acti-
vation), consistent with either free NO or an S-nitrosothiol-
containing species being the active agent (36, 37).
A proposed reaction responsible for the generation of long
lived forms of bioactive NO is the nitrite anhydrase (NA) reac-






  NO¡ HbFe2  N2O3
REACTION 3
The significance of this reaction is that N2O3 is a potent S-ni-
trosating agent of thiol-containing molecules such as glutathi-
one (GSH). The resulting S-nitrosothiols are long lived bioac-
tive materials that duplicate many of the reactions of free NO.
TheNA reaction as initially proposed has raised concerns from
several perspectives. The affinity ofmetHb for nitrite is low and
is in fact substantially lower than that for NO. This consider-
ation of affinity suggests that the pathway for the proposed
reaction would have to progress via the nitrite reacting with the
ferric heme-bound NO (38). It has been shown that the reduc-
tive nitrosylation (RN) reaction where the ferric NO derivative
undergoes reduction to the stable “dead-end” ferrous NO
derivative can be quite rapid, raising the question as to whether
theNA reaction can compete with the RN reaction under phys-
iological conditions (10, 39). The other serious concern is based
on the thermodynamics not favoring the reaction in which free
N2O3 is generated (40).
Studies using glassy matrices (41), sol-gels (14, 42), and solu-
tions (14, 42) have provided evidence for the formation of a
spectroscopically distinct species that is being proposed as a
relatively stable ferrous-N2O3 intermediate associated with the
NA reaction. This species could in principle preserve NO bio-
activity in amanner analogous to that proposed for the S-nitro-
sothiol derivative ofHbA (SNOHb) (43–46). The spectroscopic
signature of this proposed intermediate has been used to pro-
vide evidence both that the NA reaction can proceed with
either nitrite or NO binding first to the ferric heme and that the
reactivity of the nitrite for ferric heme-bound NO is much
higher than anticipated based on its low binding affinity for free
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ferric heme (14). Additionally the study showed that the NA
reaction could efficiently compete with the reductive nitrosyla-
tion process initiated by the binding of NO to the met heme,
resulting in the dead-end ferrous NOHbA (14). Recent studies
onHbA indicate that this proposed intermediate is stable in the
absence of excess NO and is capable of directly reacting with
GSH to yield S-nitrosoglutathione (GSNO) in the absence of
oxygen (14). These findings all raise the possibility that the NA
intermediatemight be a significant player in the complex inter-
play of nitrite, NO, GSH, and hemoglobin. As a consequence, it
is of interest to examine the relative efficacy with which LtHb
forms the intermediate relative to HbA.
Although there is experimental support for the existence of
the NA reaction and for the formation of N2O3-bound heme
NA intermediate, the reactions, existence, and relevance of the
NA intermediate are still speculative and controversial. To this
end, the current study also sought to further substantiate the
existence of theNA intermediate and establish the properties of
the NA intermediate in both HbA and LtHb.
The present study compared HbA and LtHb with respect to
the following reactions and processes: 1) reduction of the met
derivatives by L-cysteine (as well as redox potential measure-
ments of the intact LtHb and its subunits), 2) the nitrite reduc-
tase reaction, 3) the ability to form the intermediate associated
with the nitrite anhydrase reaction, and 4) the ability of the
nitrite anhydrase reaction to compete with reductive nitrosyla-
tion. Additionally, the NA “intermediates” of both HbA and
LtHbwere probed to further test the validity of the N2O3-heme
assignment. EPR spectroscopy was used to differentiate
between ferrous NOHb and the proposed NA intermediate,
which share similar features in the absorption spectra. The
reactivity of the NA intermediate was evaluated with respect to
the production of the triazole derivative of the NO probe 4-
amino-5-methylamino-2,7-difluorescein (DAF-FM) and of
the S-nitroso derivative of glutathione under oxygen-free con-
ditions. Under oxygen-free conditions, these reactions require
the formation of N2O3 and as a result are a means of testing the
assignment for the proposed NA intermediate.
EXPERIMENTAL PROCEDURES
Solution Preparation
All commercial reagents were purchased from Sigma in the
purest form available.
The oxygenated derivative of hemoglobin A was prepared
and obtained as described previously (14, 34, 42). The oxygen-
ated derivative of LtHb was prepared and characterized as
described in earlier work (17, 18). All reactions were conducted
in 0.05 M Bis-Tris, pH 7.0. The ferric derivative of LtHb was
prepared from stock solutions of oxy-LtHb in 0.05 M Bis-Tris,
pH 7.0 buffer that were treated with a solution of potassium
ferricyanide (K3Fe(CN)6), which was subsequently removed by
spin column, to form the aquomet (ferric) derivative. Deoxy-
LtHb was prepared from the met derivative by first purging the
solution with argon followed by reduction with a slight excess
of dithionite. NO was added to Hb samples in the form of ali-
quots of solution containing diethylamine NONOate (Sigma)
(aminemolecules that releaseNO in a time- and pH-dependent
manner) to the argon-purged deoxy derivative to form the
Fe2NO derivative and to argon-purged metLtHb to form the
Fe3NO derivative. The comparable derivatives of HbA were
prepared similarly. The absorption spectra for these derivatives
of LtHb and HbA are very similar but with some small wave-
length differences. The main UV/visible absorption peak posi-
tions for each of these species for both LtHb and HbA are pre-
sented in Table 1. The full visible spectra of these species and of
a proposedNA intermediate are shownunder “Results.” A basis
set derived from the spectra of these derivatives was used to
determine the distribution of populations contributing to the
overall observed spectrum at a given time point during the time
course of the different NO/nitrite-related LtHb and HbA reac-
tions described below.
Spectral Analysis
All ligation and redox states and reactions were monitored
spectroscopically using either a Lambda 2 (PerkinElmer Life
Sciences) or an Evolution 300 (Thermo Scientific, Madison,
WI) spectrophotometer both to characterize absorption spec-
tra of stable starting populations and to follow the changes in
the absorption spectrum of hemoglobin as a function of time
once a reaction was initiated.
Deconvolution of Stable and Time-dependent Absorption
Spectra
The absorption spectra of evolving solution samples were
repetitively scanned at regular time intervals over extended
periods of time. Each spectrum was deconvoluted using a basis
set consisting of Fe2NO, Fe3NO2, aquomet, and Fe3NO,
which were prepared individually as described above. Spectral
data were deconvoluted using a program in Mathcad v.14.0
(PTC Inc., Needham, MA) as described previously (14, 34) and
the basis set as described above. In the case of the NA reaction,
the fitting required the addition of another basis set that was
assigned to the NA intermediate as described earlier for HbA
(14) and under “Results” for LtHb.
Nitrite Reductase
All solutions and buffers were purged with argon.
Deoxy-Hb samples were prepared in an oxygen-free glove
box. Nitrite reductase reactions were performed in parallel
(HbA and LtHb) experiments using the argon-purged deoxy
derivative (0.20mM heme) of either LtHb or HbA in the pres-
ence of 1 mM dithionite to which was added aliquots of solu-
tions of nitrite prepared in argon-purged buffer. The ratio of
nitrite to hemewas varied over a range of 0.5:1 to 10:1. Changes
in the deoxy Soˆret 430 nm band were recorded as a function of
TABLE 1
Peak positions for Hb absorption bands (nm)
Ligation statea
HbA LtHb
Sôret Q band Band III Sôret Q band Band III
Oxy 415 541, 577 418 541, 576
Deoxy 430 555 757 429 559 762
Aquomet 406 500, 630 396 503, 629
Fe3 nitrite 412 536, 567 415 537, 568
Fe2NO 418 544, 575 417 543, 572
Fe3NO 417 535, 565 416 534, 564
a 0.05 M Bis-Tris, pH 7.0.
Evaluating NO Bioactivity in Earthworm Erythrocruorin
JANUARY 2, 2015•VOLUME 290•NUMBER 1 JOURNAL OF BIOLOGICAL CHEMISTRY 101
time.This choice is based on the relatively large extinction coef-
ficient for deoxy-Hb at this wavelength (133,000 M1 cm1)
compared with NOHb (8400 M1 cm1) and metHb (4000
M1 cm1). Under these conditions, the nitrite reductase reac-
tion is modified in that the met(Hb) product generated from
the nitrite reductase reaction is reduced back to deoxy-Hb by
the excess dithionite. The deoxy-Hb binds NO, yielding the
ferrous NO derivative of Hb (NOHb). As a result, the moni-
tored reaction consists overwhelmingly of the loss of deoxy-Hb
and the formation of NOHb. The initial linear portion of the
curve was used to calculate the initial rates using three or more
trials. Exponential rates were calculated using the decay curve
with a program inOrigin 8.5 (Originlab, NorthHampton,MA).
Productswere verified through full UV/visible absorption spec-
tra generated after the 430 nm band no longer changed. Under
the conditions used for these measurements, the kinetic traces
for HbA only reflect the T state kinetics. In our previous work,
we showed traces that manifest the initial T state population
switching over to the faster reacting R state population (31, 34).
Reductive Nitrosylation
All solutions and buffers were purged with argon. Samples
of aquometHb were prepared in an oxygen-free glove box.
Reductive nitrosylation experiments on LtHb and HbA were
conducted in parallel by adding an aliquot of diethylamine
NONOate (amine molecules that release NO in a time- and
pH-dependentmanner) to a solution of the argon-purged ferric
derivatives (0.30 mM heme) of HbA or LtHb. Evolution of the
sample was monitored by scanning the complete spectrum
from 350 to 850 nm every 5 min at a scan rate of 240 nm/min.
The resulting spectra were deconvoluted as described below
using the basis set established above to establish the fraction of
each contributing species as a function of time.
Nitrite Anhydrase
All solutions and buffers were purgedwith argon. Aliquots of
diethylamine NONOate were added to the ferric derivative of
the protein in 0.05 M Bis-Tris, pH 7.0 (0.30 mM heme) in the
presence of varying levels of initially added nitrite (starting at
1:1 heme up to an excess of nitrite of 30 mM). The evolution of
hemoglobin populations was followed by monitoring spectral
changes as a function of time as for reductive nitrosylation. The
data were deconvoluted as described above using the basis set
established above for LtHb andHbA. In some cases,NONOates
were added in small incremental aliquots to samples saturated
with nitrite (30 mM) to deliver NO more slowly to the ferric
nitrite complex.
Reduction by L-Cys
Samples were purged with argon as were all buffer solutions
and were prepared in an oxygen-free glove box. Reactions were
performed anaerobically. A stock solution of reduced L-Cyswas
prepared in argon-purged buffer. A 2 mM aliquot of L-Cys was
added to a ferric solution (0.30 mM heme) of the protein.
Absorption spectra were scanned at regular intervals. Data
were analyzed by recording the change in the 630 nm band as a
function of time. In other experiments, L-Cys was used in con-
junction with nitrite. The L-Cys was used to slowly reduce the
ferric derivative to deoxy-Hb, which in the presence of nitrite
results in the slow production of NO and metHb through the
NR reaction. This approach allows for the slow production of
NO in the presence of nitrite and metHb.
Redox Properties of LtHb
Autoxidation Studies—Continuous spectra were recorded
from 700 to 500 nm using a double beam spectrophotometer
(Lambda 20, PerkinElmer Life Sciences) at specified time inter-
vals. All spectral determinations were carried out at 37 °C. The
rate of metHb formation was established by the changes in the
A576/A540 ratio. This method of analysis eliminates light scat-
tering effects.
Chemical Oxidation—The traditional mode of chemical oxi-
dation for Hb is potassium ferricyanide. Rates of oxidation of
Hbs were determined as described for the autoxidation studies
using fixed concentrations of potassium ferricyanide.
Redox Potential—Hb redox potential was determined by
spectroelectrochemical analysis. The determination of the for-
mal reduction potentials (E0) for each Hb was carried out using
a modified, optically transparent electrochemical cell. An elec-
trochemical cell was constructed based on a previous method
(47). Briefly, the spectroelectrochemical experiments were car-
ried out in an anaerobic air-tight optically transparent electro-
chemical cell with a 1-cm-path length cuvette. A three-elec-
trode system inside the cell was used to apply the potential and
read currents. The electrical configuration included two small
meshes of platinum connected with platinum wires placed
inside walls of the cells (working and working sense electrodes)
and Ag/AgCl reference electrode (ee009, Cypress Systems,
Lawrence, KS). The electrochemical cell was purgedwith nitro-
gen for 10 min prior to injecting protein samples. After the Hb
solution was introduced into the cell, the sample was main-
tained in the deoxy-Hb state by fluxing nitrogen for 1 h. The
electrochemical cell was placed in the cell holder in the sample
compartment of a spectrophotometer (Lambda 20). Potential
control of the three-electrode system was powered by a poten-
tiostat/galvanostat (Model 273A, EG&G Princeton Applied
Research, Princeton, NJ) for cyclic voltammetric studies. All
potentials were measured relative to the Ag/AgCl electrode.
Spectroelectrochemistrymeasurementswere carried out at 430
nm for deoxy-Hb and 406 nm ferric (met)Hb. The potential of
the working electrode was held at a positive potential (200
mV or above depending on the Hb sample) to oxidize all Hb to
metHb and the absorbance was set at 0. Next, the potential was
reduced to the potential where the amount of reducedmaterial
was about 5% (typically by 20 mV) and held until the absor-
bance did not change (typically 5 min). The final potential
change was made from a potential where more than 95% of the
material was reduced (typically between200 and500 mV).
At this negative potential, all Hb solutions were in the reduced
state. The absorbance was taken as the total absorbance of the
Hb in the deoxy-Hb state. The spectroelectrochemical process
was repeated in the oxidative direction. In this case, the initial
potential was typically about500 mV, then the potential was
taken to about 200 mV, and the procedure continued in
reverse from that described for the reductive direction.
Hexaammineruthenium(III) chloride (Ru(NH3)6Cl3; Sigma-
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Aldrich) was used as a mediator for the electrochemically
reversible process in the oxidative and reductive directions.
The E1/2 of the Ru(NH3)6Cl3 is 150 mV at a platinum elec-
trode in the electrochemical cell containing 0.05 M MOPS,
0.20mKCl, pH 7.10. TheHb oxidation rate was slower than the
reduction rate.
The absorbances of the Hb at various potential values were
converted to a ratio of oxidized Hb form to reduced Hb form
using Equation 1whereATred-430 is the absorbance at 430 nm at
the potential where Hb was totally reduced, AToxi-430 is the
absorbance at 430 at the potential where Hb was totally oxi-
dized, andAE-430 is the absorbance at 430 nm at each potential.
[Oxidized]/Reduced ATred-430 AE-430	/AE-430 AToxi-430	
(Eq. 1)
Because the totally oxidized Hb was set to 0 (AToxi-430 
 0),
Equation 1 simplifies to Equation 2.
Oxidized/Reduced ATred-430 AE-430	/AE-430 (Eq. 2)
The log of this ratio when used to plot the function of potential
constitutes aNernst plot whereE is the potential of theworking
platinum electrode controlled by the potentiostat, E0 is the
reduction potential (log[oxidized]/[reduced] 
 0), n is the
slope, and 58.1 is the value of RT/F at 20 °C.
logOxidized/Reduced	 n/58.1	E n/58.1	E 0
(Eq. 3)
For a complex redox system like the LtHb, the formal redox
potential is difficult to define. Therefore, we define the E0 value
as the value of E0 at half-oxidation as is done for the case of
non-ideal Nernstian behavior (48). For a non-interactive sys-
tem like myoglobin, the Nernst plot is linear, and the slope n is
indicative of the number of electrons transferred. Thus nwould
be expected to be unity forMb. The complex nature of the LtHb
redox system precludes the determination of electrons trans-
ferred stoichiometrically. For the LtHb, the Nernst plot is only
linear over a small range, and the slope n, which is not constant,
is indicative of interaction and therefore will not correspond to
the number of electrons transferred (48). Conditions for all
redox measurements were 0.25 mM LtHb, 100 mM MOPS
buffer, pH 7, 0.5 mM Ru(NH3)6Cl3 mediator, 200 mM NaCl,
20 °C.
Data Analysis
The absorbances of the Hb at various potential values were
converted to a ratio of [oxidized form]/[reduced form] by using
Equation 2 where ATred-430 is the absorbance at 430 nm when
the Hb was totally reduced, AToxi-430 is the absorbance at 430
when the Hb was totally oxidized, and AE-430 is the absorbance
at 430 nm at each potential. Because the absorbance of the
[oxidized form]/[reduced form] 
 (ATred-430  AE-430)/
(AE-430  AToxi-430) (Equation 1), totally oxidized hemoglobin
was set to 0 (AToxi-430
 0), and Equation 1 simplifies to Equa-
tion 2: [oxidized form]/[reduced form]
 (ATred-430 AE-430)/
AE-430. The log of this ratio plotted as a function of potential
constitutes a Nernst plot as expressed in Equation 3 where E is
the potential of the working electrode controlled by the poten-
tiostat and E0 is log[oxidized]/[reduced] 
 (n/58.1)E 
(n/58.1)E0. The reduction potential is reported when log[oxi-
dized/reduced] 
 0, and the slope  58.1 corresponds to the
number of electrodes transferred based on theNernst equation.
58.1 is the value of RT/F at 20 °C.
Preparation of LtHb Subunits for Redox Potential
Measurements: LtHb Fractionation
Preparation of the subunits of LumbricusHb followedmeth-
ods described previously (49). Briefly, the large subunits were
isolated by dialysis of hemoglobin solution against 0.1 M sodium
phosphate buffer, pH 6.8. Then a sample of 20mg in 0.5 ml was
applied to a column of Sephadex G-150 and eluted with the pH
6.8 buffer. The small subunits were prepared by dialysis of a
hemoglobin solution against 0.1 M sodium carbonate buffer, pH
10 for 2 h. Then a sample of 15 mg in 0.3 ml was applied to a
column of Sephadex G-75 and eluted with the pH 10 buffer.
Flow rates of 1–1.5 ml/h were used, and 0.25-ml fractions were
collected and read at 280 nm.
EPR Comparison of the Ferrous Nitrosyl Derivatives of HbA
and LtHbwith NA Intermediates fromHbA and LtHb
Given the similarity between the UV/visible spectra of fer-
rous NOHb derivatives of HbA and LtHb and their respective
spectra attributable to the proposed NA intermediate, it was
essential to establish whether the two derivatives from each
protein exhibited different EPR signals. Whereas the ferrous
NO derivative has a strong EPR signal derived from the free
radical nature of the ferrous heme-bound NO, the proposed
assignment for the NA intermediate, i.e. a ferrous heme-bound
N2O3, should not be EPR-active.
Preparation of EPR Samples—All solutions of protein and
salts were prepared using argon-purged buffer. All samples
were prepared in an oxygen-free glove box. A stock solution of
metHbA (0.35mM in heme)was prepared in 0.05MBis-Tris, pH
7.0. This solution was used to generate Fe2NO, Fe3NO, and
Fe3Hb as standards for the EPR measurements. An aliquot of
this solution was also used to prepare Fe3 nitrite. The NA
intermediate was prepared by adding 10–30 mM nitrite to an
aliquot of metHbA followed by 0.115 mM NONOate. The
sample was allowed to evolve for 1 h until the intermediate
spectrum was observed. At that point, 15% glycerol was added,
and the sample was frozen in liquid nitrogen. A solution of
metLtHb (0.3 mM in heme) was prepared similarly in 0.05 M
Bis-Tris, pH 7.0. This solution was used to generate Fe2NO,
Fe3NO, Fe3 nitrite, and Fe3Hb. To prepare the intermedi-
ate, 30mM nitrite was added to an aliquot of the solution. Vary-
ing amounts of NONOates were added to individual solutions
of themet nitrite. Each solution was allowed to evolve for about
1 huntil the intermediate spectrumwas observed.At that point,
15% glycerol was added, and the samples were frozen in liquid
nitrogen. In all cases, the distribution of contributing Hb deriv-
atives was determined as described above using the deconvolu-
tion of the absorption spectrum of the sample at the point at
which it is frozen and made ready for the EPR measurement.
EPR Measurements—X-band (9-GHz) EPR measurements
were made using a Varian E-112 spectrometer interfaced to a
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PC using custom written software. Samples were pipetted into
4-mm quartz EPR tubes and frozen over a bath of liquid nitro-
gen. A fingerDewar filledwith liquid nitrogen and inserted into
the TE102 EPR cavitymaintained the sample at 77K throughout
the measurements. The field was calibrated using a standard
sample ofmanganese doped inMgO (50). Spectrometer param-
eters used to acquire spectra are listed in figure legends.
DAF-FM as a Probe of the NA Intermediate
The fluorescence and absorption spectra of diaminofluores-
ceins such as DAF-FM (51, 52) undergo a substantial change
when the triazole derivative is formed (51–56). The fluores-
cence emission increases dramatically, and the peak position
shifts several nanometers from 508 nm to as high as 515 nm.
Similarly, the absorption peak in the visible region also shifts
from 488 to 496 nm upon formation of the triazole derivative.
These changes are routinely used to detect NO production, but
oxygen is required to react with the NO to formN2O3, which is
required to produce the triazole. NO by itself is not capable of
generating the triazole derivative. In this study carried out
under oxygen-free conditions, the spectroscopic changes were
used to provide additional evidence that theNA intermediate is
a heme-bound N2O3 derivative. A comparison under oxygen-
free conditions of the spectroscopic changes in the absorption
and fluorescence spectra of DAF-FM for the ferrous NO deriv-
atives and for the NA intermediate was made for HbA and
LtHb. The comparison was in effect made by adding NO
(NONOates) to samples of metHbs (0.30 mM) with and with-
out additionally added nitrite and allowing the samples to
evolve for varying time intervals before adding DAF-FM (5 M
from a stock solution in DMSO) under oxygen-free conditions.
The sample withNONOates but without added nitrite was pre-
pared in anticipation of it evolving through reductive nitrosy-
lation to the ferrousNOHb derivative, whereas the sample with
both NONOates and nitrite was anticipated to yield a substan-
tial population of the proposed NA intermediate. Absorption
spectroscopy was used to confirm the formation of the two
derivatives of Hb. Under anaerobic conditions, the NA inter-
mediate was expected to be much more effective compared
with the ferrous NOHb sample in generating the triazole deriv-
ative of the DAF-FM. The samples containing DAF-FM were
excited using 475 nm rather than the peak wavelength 495 nm
to better observe changes in the emission spectrum.
HPLCMeasurements
HPLC was performed on a Restek C18 5-m reverse phase
column (250 4.6mm; Restek Corp., Bellefonte, PA). The run-
ning buffer was 10 mM KPO4 buffer, 10 mM tetrabutylammo-
nium bisulfate, 5% acetonitrile, pH 7.0 at a flow rate of 1
FIGURE 1. A comparison between HbA (traces A) and LtHb (traces B) of the rate of nitrite reductase at pH 7.0 monitored as the decay of the 430 nm
Soˆret band as a function of the nitrite to heme ratio: 1:1 (a), 2:1 (b), and 5:1 (c). The heme concentration in all cases was0.20mM. The red lines represent
fits to the data using Origin 8.5 as described under “Experimental Procedures.” The traces were all normalized to better expose the comparison of the kinetics.
TABLE 2
Deoxy-LtHb nitrite kinetic rates in 0.05 M Bis-Tris, pH 7.0 (M/s)
(LtHb deoxy)NO2 Percent fast phase
Rate
Fast phasea Slow phaseb
300:1 (0.120 mM) 10 0.143 0.035
5:1 (0.260 mM) 20 0.0485 0.003 0.012 0.001
2:1 (0.184 mM) 9 0.018 0.002 0.0038 0.0012
1:1 (0.227 mM) 17 0.0635 0.011 0.0036 0.0009
0.5:1 (0.169 mM) 13 0.046 0.008 0.0028 0.0006
a Calculated using an exponential fit (y
 y0 Aekt) to the slope, corrected for
the concentration.
b Calculated by using a linear fit (y
mx b) in Origin 8.5 to the last part of the
data.
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ml/min. Samples were run using a Shimadzu HPLC equipped
withClassVPV. 7.4 software (Shimadzu, Kyoto, Japan). Elution
times and UV-visible spectra were compared with authentic
standards of nitrite, GSNO, glutathione disulfide, and GSH
(Sigma) prepared and run using the same elution buffer.
All solutions of protein and salts were prepared using argon-
purged buffer. All samples were prepared in an oxygen-free
glove box. A stock solution of metLtHb (0.3 mM in heme) in
0.05 M Bis-Tris, pH 7.0 was prepared and divided into two sam-
ples of equivalent volume. One-half was treated with both
NONOates andnitrite to produce theNA intermediate, and the
second sample was treated with NONOates alone and allowed
to evolve into the ferrous NO derivative.
LtHb NA Intermediate—The sample being evaluated as the
LtHb NA intermediate was prepared by first adding nitrite to a
final concentration of 30 mM followed by NONOates (0.115
mM). The sample wasmonitored by absorption spectroscopy as
it evolved. When the intermediate spectrum was observed, the
buffer was removed by spin column and replaced with argon-
purged buffer to whichwas added 5mMGSH and 0.5mMdieth-
ylenetriaminepentaacetic acid, the copper chelator. The sample
was incubated for 1 h after which the buffer was again removed
by spin column, and the eluent was run on an HPLC column.
Ferrous LtHbNO Control—The second solution was treated
only with NONOates in the identical manner as described
above for NA intermediate sample but without any added
FIGURE 2. A comparison of the Nernst titrations for LtHb, the large and
smaller LtHb subunits, HbA, and myoglobin (horse heart). See “Experi-
mental Procedures” for a full description of how the curves were generated.
oxi, oxidized; red, reduced.
FIGURE 3. A comparison of the rate of reduction of the aquomet deriva-
tive of HbA (A) and LtHb (B) by L-cysteine at pH 7.0. The reduction was
followedbymonitoring the change in absorbanceof the 630nmbandofHbA
(A) andLtHb (B). The red lines represent fits to thedatausingOrigin8.5. Protein
concentration was 0.308 in A and 0.304 in B. L-Cys concentration was 2mM in
both cases.
TABLE 3
Deoxy-HbA nitrite kinetic rates in 0.05 M Bis-Tris, pH 7.0
(HbA deoxy)NO2 Initial ratea Rateb
M/s 1/s
5:1 (0.304 mM) 0.377 0.488
5:1 (0.248 mM) 0.602 0.403
2:1 (0.291 mM) 0.159 0.202
1:1 (0.230 mM) 0.135 0.148
0.5:1 (0.311 mM)-0 0.09 0.062
a Calculated by using a linear fit (y
mx b) in Origin 8.5 to the initial slope of
the data.
b Calculated using Origin 8.5 (y
 A0e
kt) to the slope, normalized to the
concentration.
TABLE 4






LtHb (small subunits) 30 2
LtHb (large subunits) 150 8
TABLE 5
Percentage of aquomet reduced by L-Cys
L-Cys reductiona HbA LtHb
% %
2 mM 50 16
5 mM 50 17
a 0.30 mM aquomet (heme), 0.05 M Bis-Tris, pH 7.0.
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nitrite. The metLtHb  NONOate sample was allowed to
evolve to Fe2NO as determined by absorption spectroscopy.
The buffer was removed by spin column and replaced with 5
mM GSH and diethylenetriaminepentaacetic acid in argon-
purged buffer. The sample was allowed to evolve for 1 h after
which the buffer was removed, and the eluent was run on the
HPLC column.
RESULTS
Nitrite Reductase—Fig. 1 shows a comparison between HbA
and LtHb with respect to the normalized nitrite-induced decay
of the deoxyheme population as a function of the ratio of added
nitrite to heme while keeping the heme concentrations rela-
tively fixed. It can be seen that at all ratios of nitrite to heme
LtHb appears to exhibit two distinct phases, whereas under
these conditions only one phase is observed for HbA. Exponen-
tial rateswere calculated using both single anddouble exponen-
tial fitting algorithms associated with the program inOrigin 8.5
(y 
 y0  Aekt or y 
 y0  A1ekt1  A2ekt2). For HbA, a
single exponential algorithm fit extremely well; however, for
LtHb, the single exponential fit was poor, whereas the double
exponential fitwasmuchbetter.Thegoodness of fit for eachof the
kinetic curveswasdeterminedbycomparingboth theR2 valueand
the 2 value for each equation used. Fits were chosen that had R2
values closest to 1 (0.97–0.99) or 2 values of 104 or less.
Under these conditions, only the T state contributes to the
observed trace for HbA (31, 34). LtHb does not undergo any
R/T allosteric transitions; hence the two distinct phases for
LtHb are likely to be attributable to different heme populations.
The rates displayed in Tables 2 and 3 show that the faster initial
FIGURE4.Acomparisonof the rate andefficacyof reductivenitrosylationbetweenHbA (A) andLtHb (B) uponaddinganaliquotofNO (1:1,NONOate:
heme) to the metHb derivatives at pH 7. The populations shown were derived from deconvoluting the evolving absorption spectra subsequent to the
addition of the NONOates to the Hb solutions at time 0. Insets show a representative series of visible absorption bands generated during the course of
the reactions. The fittings of these absorptionbandswere used toderive the evolutionof thepopulations. The time sequence for the shown spectra starts from
the bottom spectrum.
Evaluating NO Bioactivity in Earthworm Erythrocruorin
106 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 1•JANUARY 2, 2015
components of the decay curve for LtHb are also consistently
slower than the initial rates of decay observed for HbA. The
slow phase is consistently much slower than the overall decay
seen for HbA. The fraction of the total LtHb population under-
going the faster initial decay appears to be consistently below
20% as seen from Table 2. Despite initiating these measure-
ments at the exact moment the reagents were mixed, there is
still some scatter with respect to the fraction of fast and slow
decay components that is attributable to the difference in the
exact start times for themeasurements. The intent of these data
is to demonstrate the difference between the proteins. Detailed
evaluation of rates and rate constants requires a more compre-
hensive study that is planned for the future.
Redox Potentials—Fig. 2 shows both the Nernst plot redox
titrations and the corresponding slopes for LtHb, LtHb sub-
units, HbA, and Mb. Table 4 contains the measured redox
potentials of Mb, HbA, LtHb, and two LtHb subunits. The
ordering of the redox potentials follows previously published
results with Mb having the lowest value and LtHb having the
highest (27, 57). The two LtHb subunits have dramatically dif-
ferent values with the larger subunits having an extremely high
positive value and the smaller subunit having a negative value
but not as negative as either HbA or Mb.
Reduction ofmetHb by L-Cysteine—In vivo reductants such as
L-Cys are of potential relevance in mediating redox activity of
Hbs (58). Fig. 3 shows the comparison between HbA and LtHb
with respect to the rate of L-Cys-induced reduction of the
aquomet derivatives of the two Hbs. The rate for LtHb is sub-
stantially faster than for HbA, consistent with LtHb having the
higher redox potential. An analysis of the fraction of the total
population undergoing reduction revealed that less than 20% of
the population undergoes the reduction even in the presence of
excess L-Cys. For HbA under the same conditions, 50% of the
initialmet population undergoes reduction, suggestive of an
chain difference in reactivity with respect to L-Cys-induced
reduction. These percentages are shown in Table 5.
Reductive Nitrosylation—Fig. 4 compares HbA and LtHb
with respect to the rate of reduction of metHb with concomi-
tant formation of the ferrous NO derivative by the addition of
stoichiometric amounts of NO (supplied via NONOates). This
figure and most of the subsequent figures show the time evolu-
tion of the different populations of Hb derivatives based on
fittings (see “Experimental Procedures”) using the series of
time-ordered spectra that are shown as an inset in each of these
figures (the temporal series starts with the bottom spectrum).
The results show that the RN process is faster for LtHb. This
enhanced rate for LtHb was observed under a wide range of
added NONOate concentrations (data not shown).
Nitrite Anhydrase—Earlier work on HbA demonstrated the
formation of a spectroscopically distinct species formed when
both NO and nitrite are added to metHbA (14, 34, 41). That
species was assigned in those earlier studies as the NA interme-
diate in which N2O3 is coordinated to a ferrous heme. It was
also shown that the species associated with the NA intermedi-
ate can generate S-nitrosothiols such as GSNO (14). It was
shown based on the formation of this spectroscopically distinct
species that for HbA the NA reaction can effectively compete
with the RN reaction (14, 34). Here we addressed whether the
intermediate can be generated by LtHb and, if so, whether the
NA reaction can compete with the RN reaction given the high
redox potential and fast rate of RN for LtHb. As was done with
HbA, we started with an excess of nitrite (30mM), thus creating
a substantial population ofmet nitrite for LtHb. The addition of
a small amount of NO (via NONOates) resulted in the transfor-
mation of the met nitrite spectrum to one that resembles the
HbA intermediate. The same transition occurredwhen low lev-
els of NO were slowly generated by deoxy-LtHb produced by
the addition of the reductant L-Cys to an LtHb sample with a
large initial population of met nitrite. Fig. 5 compares for both
LtHb and HbA the Q band spectra of the intermediate with the
Qband spectra from ferric and ferrousNOderivatives and from
the met nitrite derivative. Table 6 lists the spectral peaks for all
FIGURE 5. A comparison of the Q band (i.e. the major visible heme-associ-
ated absorption peak) absorption spectrum of the NA intermediate with
the spectra of several stable well known derivatives of HbA (A) and LtHb
(B) at pH 7.
TABLE 6
Peak positions for Hb absorption bands (nm)
Ligation statea
HbA LtHb
Sôret Q band Sôret Q band
NA intermediate 417 539, 569 416 539, 570
Fe2NO 418 544, 575 417 542, 572
Fe3NO 417 535, 565 416 534, 564
Fe3 nitrite 412 536, 567 415 537, 568
a 0.05 M Bis-Tris, pH 7.0.
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of theseNOx-related species. The spectrum of theNA interme-
diate was then used as a member of the basis set to fit the
evolving populations during the course of reactions in which
both NO and nitrite were added or generated. Fig. 6 compares
the evolution of populations for metLtHb upon addition of a
very low amount of NONOates in the presence (A) and absence
(B) of an excess of nitrite. In the presence of the large excess of
nitrite, the addition of the NONOates generates primarily the
intermediate, whereas in the absence of nitrite, the addition of
the identical low amount ofNONOate triggers the RN reaction.
It can be seen that at this level of added NO the RN reaction
does not go to completion but instead plateaus after a rapid
initial buildup of the ferrous NO derivative of LtHb. The addi-
tion of a second aliquot does drive the reaction to near comple-
tion but at a slower ratewith a noticeable buildup of themetNO
derivative prior to formation of the ferrousNOderivative. Fig. 7
shows the evolution of an initial population of the met nitrite
derivative of LtHb upon addition of very small aliquots of
NONOates to a metLtHb sample in the presence of excess
nitrite. The pattern is very similar to that reported previously
for HbA in that there is a progressive buildup of intermediate
with addition of NO until the population of intermediate
approaches 80% after which the further addition of NO results
in the formation of the ferrous NO derivative. Fig. 8 compares
the evolution of the populations for a sample of metLtHb upon
addition of a stoichiometric amount of NO (NONOates) as a
function of initial nitrite concentration. Fig. 9 shows a compa-
rable series of traces for HbA. In both cases, the fraction of
formed intermediate increaseswith nitrite concentration; how-
ever, the fraction of intermediate relative to ferrous NO is con-
sistently much higher for HbA. Fig. 10 shows that under condi-
tions where reduction of metHbA by L-Cys in the presence of 4
mMnitrite results in the progressive buildupof intermediate the
comparable set of conditions for metLtHb produces a substan-
tial amount of deoxyheme and ferrous NO heme populations
with a much lower intermediate population that decays with
time. Similar patterns are seen for lower and higher concentra-
tions of nitrite.
The Anaerobic Response of the DAF-FM Fluorescence and
Absorption Spectra to the Presence of the NA Intermediate—
Figs. 11 and 12 show the evolution of the DAF-FM fluorescence
spectra under anaerobic conditions when DAF-FMwas added to
samples prepared as either the ferrous NO derivative or the NA
intermediate of HbA and LtHb. The absorption spectrum was
used to establish that in each case the populations were over-
whelmingly either ferrous NOHb or the intermediate. For both
HbA and LtHb, the increase in fluorescence intensity and the red
shift of the fluorescence peak were greater andmore rapid for the
sample thatmanifests the absorption spectrum attributable to the
NA intermediate (nitrite andNOboth added). A similar shift pat-
tern was seen in the absorptionmaximumof DAF-FM that is also
indicative of triazole formation for the samples manifesting the
NA intermediate spectrum (not shown).
Comparison of the EPR Spectra from NOHb and the NA
Intermediate—Fig. 13 compares for both HbA and LtHb the
EPR spectrum of populations of fully ferrous NOHb with pop-
ulations that are 70–80% “NA intermediate” based on the
population analysis of the absorption just prior to the EPR
measurements. The remainder of the population comprises
FIGURE6.Theevolutionof LtHbpopulationsatpH7 initiatedby theaddi-
tion of NONOates to the ferric derivative of LtHb in the presence (A) and
absence (B) of nitrite. In both cases, the reactionwas initiatedwith the addi-
tion of an aliquot of NONOate-containing solution to a solution of metLtHb
(0.25 mM in heme) resulting in a final concentration of 0.075 mM NONOates.
The arrow in B indicates the addition of a second identical aliquot. The
metLtHb sample used to generate A contained 30 mM nitrite. Insets show a
representative time sequence of spectra from which the populations were
derived.
FIGURE 7. The evolution of LtHb populations with a sequence of addi-
tions of aliquots of NONOates to a sample of metLtHb at pH 7 in the
presence of excess nitrite (30 mM). The arrows signify the addition of ali-
quots of NONOate-containing buffer (0.035 mM/addition). The inset shows
the time sequence of spectra from which the populations were derived.
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aquometHb, nitrite metHb, and a low level of ferrous NOHb.
The NOHbA EPR spectrum is largely consistent with that
observed previously for HbA incubated with NO to form six-
coordinate Hb(NO)4 (59, 60). It is noted that in the spectra
presented in Fig. 13B the negative peak (trough) in the spec-
trum has slightly more intensity (15%) than would be
expected for pure Hb(NO)4.We attribute this extra intensity to
underlying spectra originating from a residual small percentage
of ferric HbA, which would escape detection in the absorption
spectrum. Similar spectra have been observed in studies of NO
reactions with hemoglobin under heterogeneous conditions
(61). The contribution of this residual signal is minimal and
does not influence the overall conclusions drawn from the anal-
ysis of EPR spectra presented here. The LtHb EPR spectrum
(Fig. 13C) has a more prominent low field peak as well as par-
tially resolved 14N hyperfine splitting. These features indicate
structural differences in the heme environment relative to
NOHbA with a variation in the ligand arrangement of six-co-
FIGURE8.EvolutionofametLtHbsample (0.29mMheme)atpH7asa functionof initialnitrite concentrationuponadditionofanaliquotofaNONOate
solution yielding a final ratio of NONOate to heme of 1:1. A, 1mM nitrite initially added prior to the addition of NO; B, 10mM nitrite initially added; C, 30mM
nitrite initially added. Insets show representative time sequences of spectra from which the populations were derived.
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ordinate nitrosyl hemes and/or a contribution from five-coor-
dinate species (59, 60). Further characterization of the EPR
spectra from both NOHba and NOLtHb is in progress.
For both HbA and LtHb, the concentration of protein is the
same for the NOHb and NA intermediate samples. Thus for
both HbA and LtHb comparisons, the EPR signals are derived
from samples that are 100% ferrous HbNO (control) and sam-
ples that have a 70–80% population of the NA intermediate
with the remainder of the population a mixture of met deriva-
tives and ferrous NOHb. It can be seen in both cases that the
signal from the composite sample is substantially less than for
the fully ferrous NO sample. The residual ferrous NO signals
for the HbA and LtHb NA intermediate samples are 25 and
50% of the control ferrous NOHb samples, respectively. Vary-
ing thepercentageofHbNOandNAintermediate (usingdifferent
concentrations of NONOates and nitrite) produce EPR spectra
that scale with the fraction of ferrous NO; i.e. the greater the per-
centage of ferrous NO relative to NA intermediate in the popula-
tion analysis, the greater is the intensity of the EPR signal. Most
significant is that the inclusionofnitritealways lowers the intensity
of theEPRsignal relative to that fromthe identical sample towhich
is added the same amount of NONOates. In all cases, the fraction
of metHb is very low compared with the composite population of
HbNO andNA intermediate.
FIGURE9.Evolutionof ametHbAsample (0.29mMheme)atpH7asa functionof initial nitrite concentrationuponadditionof analiquotof aNONOate
solution yielding a final ratio of NONOate to heme of 1:1. A, 1:1 nitrite initially added prior to addition of NO; B, 1 mM nitrite initially added; C, 10mM nitrite
initially added. Insets show a representative time sequence of spectra from which the populations were derived.
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NA Intermediate of LtHb Can Generate GSNO: HPLC
Result—Fig. 14 compares the absorption spectrumof theHPLC
eluent in the region of the observed peak for GSNO for two
samples of metLtHb to which was added NONOates with and
without nitrite. As described under “Experimental Procedures,”
the samples were allowed to evolve to the point where the sam-
ple without added nitrite was fully ferrous NOHb and the
nitrite-containing sample was predominantly the NA interme-
diate. At that point, GSH was added, and the samples were
treated as described under “Experimental Procedures.” The
eluent spectrum from the sample that underwent the full
nitrite plus NO protocol shows the same eluent spectrum as
the GSNO standard (plus substantial residual GSH). No such
spectrum is observed for the eluent from the control sample
without nitrite. This observation is indicative of GSNO forma-
tion occurring under anoxic conditions for the sample with
LtHb plus nitrite plus NO but not for the sample with only
added NO. From the initial concentration of the standard
GSNO, and allowing for the dilutionwithin the tubing, the con-
centration of GSNO in the eluent from the LtHb sample can be
directly calculated from the spectrumusing the extinction coef-
ficient and an integration of the GSNO elution band. Based on
the absorbance and integrated intensity, we found that the
amount of GSNO formed from the initially added GSH corre-
sponds to less than 10% of the total number of hemes in the
LtHb sample being active with respect to converting GSH to
GSNO. The fact that (i) the LtHb sample is not fully converted
to the NA intermediate under the conditions of this experi-
ment, (ii) theNA intermediate for LtHb appears less stable than
for HbA, and (iii) the time lag in adding the GSH after forma-
tion of the moderately unstable LtHb NA intermediate all indi-
cate that the derived number underestimates the efficacy with
which the intermediate generates GSNO from GSH. The low
yield for the nitrite plus NO and the zero yield for the NO
without nitrite also indicate that there were no issues of an
oxygen leak in the presence of residual NObecause under those
conditions one would observe a much larger yield of GSNO.
GSNO formation from HbA under similar conditions was
reported previously (14).
DISCUSSION
The tendency of the iron centers in Hb to gain or lose elec-
trons is reflected by their intrinsic redox potentials. These Hb
redox potentials are physiologically important because iron
FIGURE10.Acomparisonof theevolutionof the ferricderivatives (0. 3mM)ofHbA(A) andLtHb (B) in thepresenceof4mMnitriteatpH7uponaddition
2 mM L-cysteine. Insets show a representative time sequence of spectra from which the populations were derived.
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oxidation states influence both axial ligand binding and redox-
mediated reactivity. The current study confirms the previously
reported findings (27, 57) that the redox potential of LtHb is
very high relative to both HbA and myoglobin. The present
study also shows that the isolated large and small subunits have
very different redox potentials. The redox potentials of the indi-
vidual subunits are both more positive than the redox poten-
tials of HbA and myoglobin. The redox potential associated
with the larger LtHb subunits is dramatically higher than all of
the others. The large difference in the redox of the isolated
subunits is consistent with the several manifestations of func-
tional heterogeneity seen in the intact polymer. Future studies
will examine the reactivity of the individual subunits to deter-
mine whether the differences in redox potential match with
differences in redox-sensitive reactions such as the nitrite
reductase, reductive nitrosylation, and reduction by L-Cys.
The high redox potential of LtHb is a plausible explanation
for several functional observations. The rates of reduction by
L-Cys of the met derivative of LtHb and HbA with respect to
L-Cys are consistent with the higher redox potential for LtHb in
that the rate of reduction for the LtHb is considerably faster.
The low fraction of ferric hemes in LtHb that are reduced by the
L-Cys could be a reflection of heterogeneity in either the redox
potential or accessibility of L-Cys for the different heme sites.
Similarly the report of reduced rates for the nitric oxide dioxy-
genase reaction in both LtHb (17, 18) and another large poly-
meric worm hemoglobin (26) is also consistent with either a
very high redox potential or low accessibility of reagents into
the distal heme pocket of these proteins for at least some sites,
possibly the result of a reduced volume within the distal pocket
relative to HbA and myoglobins.
Several studies have provided evidence that the rate of the
nitrite reductase reaction of heme proteins scales inverselywith
redox potential (33, 34). That relationship accounts at least in
part for the higher NR rate for the R state of HbA versus the T
state (8, 10, 30–32, 34, 36, 62). Overall the present study sup-
ports the extension of these earlier findings to LtHb in that the
overall rate of the NR reaction is much slower than for HbA,
consistent with the ordering of the redox potentials. The rates
for the autoreduction of the Fe3NO derivatives (RN reaction)
follow a similar pattern in that the LtHb derivative undergoes
RN at a much faster rate than HbA as anticipated based on the
ordering of the redox potentials. The clear cut biphasic nature
of the NR time course for LtHb is again consistent with func-
tional heterogeneity among the heme sites in LtHbwith respect
to redox potential as anticipated from the redox potentials from
the isolated subunits. This functional heterogeneity for LtHb
could allow it to function both as a highly stable oxygen trans-
port protein and as an NO/nitrite-detoxifying agent (28, 63).
The need for critically important dual functionalities in a single
FIGURE 11. Changes in the DAF-FM fluorescence emission for HbA solutions. The increase and the shift in the emission spectrum of DAF-FM as a function
of time subsequent to the addition of the fluorophore (5 M final) to a solution of HbA (0.3 mM) are shown. A, metHbA to which was added both nitrite and
NONOates toproduce theNA intermediate.Black line, initial spectrumuponaddition; red line, change in the emission after 20min;blue line, change in emission
after 40 min. B, control ferrous NO sample in the absence of nitrite as described under “Experimental Procedures.” Black line, initial emission spectrum upon
addition of 5MDAF added to theprotein-NO complex; red line, change in the emission after 20min; blue line, change in emission after 40min.C, the evolution
of the population distribution profile for the sample prepared to promote formation of the NA intermediate and then evaluated using DAF-FM as described
under “Experimental Procedures.”D, the evolution of the population distribution profile for the control ferrous NO sample to which DAF-FMwas added. inter,
intermediate.
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hemoglobin is a possible driving force for the evolution of sub-
units that require different redox properties.
In thepresenceof anexcessofnitrite, the additionof stoichio-
metric amounts (with respect to heme) of NO to ferric LtHb
results in the formation a spectroscopically distinct species that
is very similar to the HbA species assigned to the NA interme-
diate that has previously been attributed to N2O3 bound to a
ferrous heme (14, 41, 42). The present study provides more
support for this assignment. The results obtained using
DAF-FM under anaerobic conditions show that the addition of
both nitrite andNO tometHb produces a population ofHb that
is more effective at generation of the triazole derivative of the
DAF-FM relative to the same samples without the nitrite. Both
the intensity changes and the wavelength changes support that
assessment. The small changes observed to the nitrite-free
sample could be due to low levels of oxygen still being present
or binding of some reagent to the DAF causing the small
changes. These results are paralleled by the HPLC finding for
HbA reported by us previously (14) and the present result for
LtHb showing formation of GSNO when both NO and nitrite
are present with metHb but not when just NO is present. That
observation is consistent with another study showing that the
addition of nitrite to a mixture of NO and metHbA enhances
GSNOproduction (39). The EPR results show that although the
absorption spectrum of the proposedNA intermediate for both
proteins closely resembles that of the corresponding ferrous
NOHb derivatives the derivative attributed to the NA interme-
diate does not appear to have a detectable EPR signature in the
region of the ferrous NOHb derivatives of either HbA or LtHb.
The reactivity of the NA intermediate under low oxygen con-
ditions and the absence of an EPR signal indicative of a ferrous
NOHb derivative along with the conditions under which the
NA intermediate is generated are all consistent with assigning
the NA intermediate species to a derivative with a heme-bound
N2O3. The absorption spectrum ismost consistent with theNA
intermediate being a ferrous derivative.
Although both HbA and LtHb form the NA intermediate,
there are clear differences in the efficacy with which this reac-
tion can compete with RN. In the absence of the nitrite, a rapid
RN reaction is observed for the LtHb. It is only when an excess
of nitrite is added that there is an appreciable formation of the
intermediate for LtHb for the pathway involving the addition of
both nitrite and NO to the met derivative. At low nitrite levels,
the RN reaction still dominates. That behavior is different from
that observed for HbA (14) where even at low nitrite and NO
concentrations the NA reaction dominates over RN (formation
of the “intermediate” is used here as indicative of the NA reac-
tion despite the NA reaction being described as having the
N2O3 released from the heme). The HbA study supported a
mechanismwhere the intermediate could form from eitherNO
or nitrite binding first; however, in situations where there is not
a large excess of nitrite, the NO binding first mechanism is
FIGURE 12. Changes in the DAF-FM fluorescence emission for LtHb solutions. The increase and the shift in the emission spectrum of DAF-FM with time
when the fluorophore (5M final concentration) was added to a solution of LtHb (0.3mM) are shown.A, metLtHb towhichwas added nitrite andNO. Black line,
initial emission spectrumuponadditionof 5MDAF to theLtHb solution; red line, change in theemissionafter 20min;blue line, change inemissionafter 40min.
B, a control ferrous NO sample in the absence of nitrite as described under “Experimental Procedures.” Black line, initial emission spectrum upon addition of 5
M DAF; red line, change in the emission after 20 min; blue line, change in emission after 40 min. C, the evolution of the population distribution profile for the
sampleprepared topromote the formationof the intermediateusedwithDAF-FMasdescribedunder “Experimental Procedures.”D, the comparable evolution
of the population distribution profile for the control sample to which DAF-FM was added. inter, intermediate.
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FIGURE 13. EPR evidence for a distinct non-ferrous NOHb species. A, a
representative trace of the population evolution for an HbA sample (0.302
mMheme) in 0.05 MBis-Tris, pH 7 towhichwas added 30mMNO2
 followedby
an initial aliquot of NONOates (0.067 mM) and two subsequent aliquots of
0.067mMNONOates (at the two arrows) resulting in a total NONOate concen-
tration of 0.201 mM. Once the purported NA intermediate spectrum devel-
oped, the sample was then prepared for EPR analysis. The control reference
samples did not have nitrite and had sufficient NONOates added to allow the
sample to evolve to a close to a fully ferrous NO sample prior to EPR analysis.
The comparisons made in the EPR used samples that had the same Hb con-
centrations for both HbA and LtHb. B, EPR spectra (X-band) of Fe2-NO spe-
cies. Solid line, normalized EPR signal in the Fe2NO region for a standard Hb
Fe2NO (0.302mM inheme);dashed-dotted line, the normalized EPR signal for
themetHbA (0.302mM in heme) in 0.05 M Bis-Tris, pH 7.0 to which was added
both nitrite and NO. EPR instrument parameters for both spectra are as fol-
lows:modulation amplitude, 5 gauss;microwavepower, 5milliwatts; receiver
gain, 1.25 103; microwave frequency, 9.12 GHz; scan time, 2 min; time con-
stant, 0.5 s; number of scans, 4; temperature, 77 K. The spectra were normal-
ized to the intensity of the standard sample. C, solid line, normalized EPR
signal in the Fe2NO region for a standard LtHb Fe2NO (0.30 mM in heme);
dashed dotted line, the normalized EPR signal for the metLtHb (0.30 mM in
heme) prepared with the addition 30 mM NO2
 and 0.115 mM NONOate.
FIGURE 14.HPLC evidence of GSNO formation via theNA intermediate of
LtHb. A, absorption spectrum recorded on the Shimadzu HPLC of the peak
eluting at the retention time for GSNO for the standard solution prepared as
described under “Experimental Procedures.” B, absorption spectrum recorded
on the Shimadzu HPLC for the eluent removed from the LtHb sample pre-
pared (nitrite and NO) to promote the formation of the NA intermediate as
describe under “Experimental Procedures.” C, absorption spectrum taken for
the eluent removed from the control ferrous NOLtHb sample (no nitrite) to
which was added GSH (note the difference in the absorption scale). mAu,
milliabsorbance units.
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claimed to be much more probable based on predictions from
simulations (38). The very low affinity of nitrite for ferric heme
in Hbs implies that nitrite-based reactivity might be compara-
bly low. The present and earlier studies (14, 34, 42) indicate that
nitrite reactivity toward ferric hemes can be quite high when
NO is present. The likely mechanism (64, 65) is NO binding
first followed by the reaction of nitrite with ferric NO/ferrous
NO resonance structure. Results obtained in trehalose-de-
rived glassy matrices (41) suggest that in the presence of an
excess of nitrite where there is a substantial population of
heme-bound nitrite it is likely that NO rapidly displaces the
bound nitrite followed by the displaced nitrite within the distal
heme pocket rapidly reacting with the newly formed ferric
NO/ferrous NO to form the ferrous N2O3 derivative.
The reactivity difference between the two proteins can be
attributable largely to the higher redox potential of LtHb,
although the difference in nitrite accessibility to the heme site
may also be a factor. The higher redox potential supports a
faster RN reaction. As a consequence, under similar low nitrite
conditions, formation of the intermediate from Fe3NO is less
likely for LtHb relative to HbA because of the relative rapidity
with which the RN occurs for LtHb. The redox potential is not
likely to be the complete story with respect to NA versus RN in
that myoglobin, which has a lower redox potential than HbA,
does not form the intermediate.3 The fact that the nitrite deriv-
ative of metMb is high spin compared with the low spin forms
seen for HbA and LtHb suggests that factors such as the inter-
nal structure of the distal heme pocket impacting both volume
and charge distributions may limit the formation of the NA
intermediate.
CONCLUSIONS
LtHb undergoes the same nitrite-based reactions as HbA but
at a much reduced efficiency and with clear evidence of func-
tional heterogeneity. As with metHbA, metLtHb in the pres-
ence of both nitrite and NO can result in the formation of a
relatively stable spectroscopically distinct species that has been
attributed to N2O3 bound to a ferrous heme. This species is
referred to as the nitrite anhydrase intermediate. The lack of an
observable EPR spectrum for this species in combination with
its reactivity under low oxygen conditions support an assign-
ment for a ferrous heme-bound N2O3. Unlike the situation for
HbA, the rate of formation of this proposed NA intermediate
for LtHb is slower than the rate of reductive nitrosylation. The
reduced reactivity of LtHb both with respect to the nitrite
reductase and nitrite anhydrase reactions relative to HbA sug-
gests that under physiological conditions where NO levels are
depleted as in endothelial dysfunction or in the event of NO
scavenging LtHb as a possible HBOCmay not be as effective as
somePEGylatedHbswith respect to compensatorymechanism
(35). The in vivo data to date indicate that LtHb can be effective
with respect to oxygen delivery under conditions where NO is
not depleted. In the event that the reduced NO/N2O3-generat-
ing capability of LtHb becomes a limiting factor for its use as an
HBOC, supplementation with NO-releasing nanoparticles is a
straightforward therapeutic solution. Sustained release of NO
through biocompatibleNO-releasing nanoparticles (66, 67) has
been shown to offset vasoconstriction due toNO scavenging by
HBOCs (68) and inhibit the inflammatory cascade triggered by
rapid blood loss (69).
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